What Is Insulin Resistance, Really?

Insulin resistance is not simply “high blood sugar.” It can begin long before glucose levels become abnormal.

By Practical Health Science Editorial Team Sep 1, 2026 6 min read
Evidence Strength
High

This rating reflects the overall strength and consistency of the available evidence.

What Is Insulin Resistance, Really?
Quick Answer

Insulin resistance means that the body needs more insulin than usual to produce the same metabolic effect.

It is not simply another name for high blood sugar. Insulin normally helps skeletal muscle take up glucose, tells the liver to reduce glucose production, and suppresses the release of fatty acids from adipose tissue. When these tissues become less responsive to insulin, the pancreas can compensate by releasing more of it. For a while, that compensation may keep blood glucose within the normal range. If insulin resistance progresses and the pancreatic beta cells can no longer produce enough insulin to compensate, blood glucose may begin to rise eventually contributing to prediabetes and, in some people, type 2 diabetes.

So insulin resistance, prediabetes, and type 2 diabetes are related but they are not the same thing.

What the Science Says

Insulin is a hormone produced by pancreatic beta cells that coordinates how the body handles incoming and stored energy. Its actions differ between tissues. In skeletal muscle, insulin promotes glucose uptake and storage. In the liver, it helps suppress glucose production and promotes glycogen storage. In adipose tissue, insulin suppresses lipolysis the release of stored fatty acids into the bloodstream. Insulin resistance occurs when these metabolic responses become impaired. This does not happen identically in every organ. Someone may have substantial hepatic insulin resistance, muscle insulin resistance, adipose tissue insulin resistance, or some combination of the three. This is one reason insulin resistance should be viewed as a metabolic spectrum rather than a simple on/off condition.

Excess visceral and ectopic fat, particularly lipid accumulation in the liver and skeletal muscle, can contribute to disrupted insulin signaling and abnormal substrate metabolism. Genetics, physical inactivity, age, sleep disorders, certain medications, endocrine conditions and other biological factors can also influence insulin sensitivity. Obesity is an important risk factor, but insulin resistance is not restricted to people with obesity.

Regular physical activity and weight reduction when clinically appropriate can substantially improve metabolic health and insulin sensitivity. Current 2026 ADA recommendations continue to emphasize physical activity and weight management for people with, or at increased risk for, type 2 diabetes.

Insulin Resistance Can Exist Before Blood Sugar Is High

This is probably the most important concept. Imagine that your tissues now require twice as much insulin to handle a meal effectively. Your pancreas may respond by producing more insulin. As long as it can compensate, your blood glucose may still look relatively normal.

This means: normal glucose does not necessarily prove perfect insulin sensitivity.

Over time, however, some people can no longer maintain enough beta-cell compensation. Glucose begins to rise, and the metabolic state may progress toward prediabetes or type 2 diabetes.

Type 2 diabetes therefore reflects more than insulin resistance alone. It typically involves a combination of reduced insulin sensitivity and inadequate pancreatic beta-cell compensation.


Is Insulin Resistance the Same as Prediabetes?

No.

Insulin resistance describes how tissues respond to insulin.

Prediabetes describes blood glucose levels that are above the normal range but below the diagnostic threshold for diabetes.

According to current U.S. criteria, prediabetes may be identified by:

  • A1C of 5.7%–6.4%

  • fasting plasma glucose of 100–125 mg/dL

  • or a 2-hour glucose of 140–199 mg/dL during a 75-g oral glucose tolerance test.

Many people with prediabetes are insulin resistant, but the two labels are not interchangeable.


Can You Test for Insulin Resistance?

Yes but there is an important catch.

The research gold standard is the hyperinsulinemic-euglycemic clamp. Insulin is infused while glucose is carefully maintained at a target concentration, allowing researchers to quantify how effectively insulin stimulates glucose disposal.

It is an excellent research tool but far too complex for routine screening.

Researchers therefore often use surrogate measures such as HOMA-IR, which incorporates fasting insulin and fasting glucose.

But HOMA-IR should not be treated as a universal consumer diagnostic test with one cutoff that applies to everyone. Insulin assays, populations and metabolic conditions vary, and fasting insulin itself is not routinely measured in many clinical settings.

For routine care, clinicians generally focus more on established diabetes-risk factors and validated measurements of glycemia such as fasting glucose, A1C and, when appropriate, an oral glucose tolerance test.


Can Insulin Resistance Improve?

Often, yes.

Insulin sensitivity is not permanently fixed. Physical activity can increase skeletal-muscle glucose uptake and improve insulin sensitivity. Reducing excess body fat particularly when it reduces ectopic and visceral fat can also improve metabolic function.

The landmark Diabetes Prevention Program randomized 3,234 adults at high risk for type 2 diabetes to placebo, metformin or an intensive lifestyle intervention targeting weight reduction and at least 150 minutes of activity per week.

Over an average 2.8 years, the lifestyle intervention reduced progression to diabetes by 58% compared with placebo, while metformin reduced it by 31%.

That trial measured diabetes prevention rather than insulin resistance alone, but it provides strong clinical evidence that the metabolic trajectory associated with insulin resistance and prediabetes is modifiable.

Limitations Summary

Insulin resistance is a useful concept, but it is easy to oversimplify. First, it is not one single biological defect. Muscle, liver and adipose tissue can each become insulin resistant to different degrees. Second, there is no universally used routine clinical test that directly quantifies whole-body insulin resistance. The hyperinsulinemic-euglycemic clamp is highly informative but mostly restricted to research, while surrogate measures such as HOMA-IR have important methodological limitations.

Third, insulin resistance does not inevitably progress to type 2 diabetes. Beta-cell function, genetics, body-fat distribution, physical activity, diet, age, medications and other factors influence progression.

Finally, terms such as “reversing insulin resistance” can imply a more binary process than the biology supports. In many people insulin sensitivity can improve substantially, but the magnitude and durability of that improvement vary.

What This Means in Real Life

You do not need to think of insulin resistance as a switch that suddenly turns on. It is better understood as a continuum. Your body may compensate for declining insulin sensitivity for years before routine glucose tests become abnormal. At the same time, a single fasting insulin value or an online HOMA-IR calculator should not be treated as a definitive diagnosis.
If there is concern about metabolic risk, established clinical information is more useful when considered together:

A1C
fasting glucose
sometimes an oral glucose tolerance test
blood pressure
lipid profile
waist and body-weight trends
family history
physical activity
medications
and other relevant health conditions.

Insulin sensitivity can also change. Regular physical activity is particularly important. Current ADA guidance recommends increasing activity among people at risk for diabetes and supports approximately 150 minutes per week of moderate to vigorous activity, with resistance exercise also playing an important role. The goal is therefore not to obsess over a single “insulin resistance number.” It is to understand and improve the broader metabolic picture.

Key Takeaway

Insulin resistance means your tissues respond less effectively to insulin not simply that your blood sugar is high.

The pancreas can initially compensate by producing more insulin, meaning insulin resistance may exist before prediabetes or diabetes becomes apparent.

It is biologically complex, difficult to reduce to a single routine test, and often modifiable through changes in physical activity, body composition and other relevant health factors.

Sources

Mechanisms of Insulin Action and Insulin Resistance
Max C Petersen, Gerald I Shulman. Physiological Reviews. 2018.
Systematic Review DOI: 10.1152/physrev.00063.2017 PMID: 30067154

Foundational evidence explaining insulin signaling and insulin resistance in skeletal muscle, liver and adipose tissue.

Measuring and estimating insulin resistance in clinical and research settings
Amalia Gastaldelli. Obesity. 2022.
Systematic Review DOI: 10.1002/oby.23503 PMID: 35894085

Primary source for how insulin resistance is measured and why the hyperinsulinemic-euglycemic clamp remains the reference method.

The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Varman T Samuel, Gerald I Shulman. Journal of Clinical Investigation. 2016.
Systematic Review DOI: 10.1172/JCI77812 PMID: 26727229

Evidence explaining ectopic lipid, skeletal-muscle insulin resistance, hepatic glucose production and adipose-tissue dysfunction

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026
American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care. 2026.
Clinical Guideline DOI: 10.2337/dc26-S002 PMID: 41358893

Current U.S. diagnostic framework for prediabetes and diabetes.

3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2026
American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care. 2026.
Clinical Guideline DOI: 10.2337/dc26-S003 PMID: 41358891

Current evidence-based recommendations concerning physical activity, weight management and prevention of type 2 diabetes.

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026
American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care. 2026.
Clinical Guideline DOI: 10.2337/dc26-S005 PMID: 41358898

Current recommendations concerning exercise, sedentary behavior, nutrition and metabolic health.

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan; Diabetes Prevention Program Research Group. New England Journal of Medicine. 2002.
Clinical Trial DOI: 10.1056/NEJMoa012512 PMID: 11832527

Landmark clinical evidence showing that progression to type 2 diabetes in high-risk adults can be substantially reduced through intensive lifestyle intervention and, to a lesser extent, metformin.

Medical disclaimer: This article is for educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for personal medical decisions.

More from Metabolic Health

Explore more Practical Health Science articles from this category.

Metabolic Health Myth Check Evidence: Moderate

Do Food Cravings Mean You’re Deficient in a Nutrient?

Social media often claims that specific food cravings reveal specific nutrient deficiencies. The biology is more complicated. Here’s what the evidence says about cravings for sugar, salt, chocolate, and carbs.

Practical Health Science Editorial Team 7 min read Sep 6, 2026
Metabolic Health Myth Check Evidence: Moderate

Do Artificial Sweeteners Spike Insulin or Cause Weight Gain?

Artificial and other non-nutritive sweeteners generally do not produce a meaningful acute insulin or glucose spike on their own. They may modestly help with weight control when they replace sugar, but long-term observational studies remain harder to interpret.

Practical Health Science Editorial Team 6 min read Sep 4, 2026